KDM5A Antikörper (AA 1416-1434)

Produktnummer ABIN3201014

Produktdetails anti-KDM5A Antikörper

Target: KDM5A (Lysine (K)-Specific Demethylase 5A (KDM5A))

Bindungsspezifität: AA 1416-1434

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser KDM5A Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Spezifität: Specific to human and mouse RBP2. Can detect endogenous levels of RBP2.

Aufreinigung: IgG fraction is purified from supernatant of culture in serum-free medium under mild conditions by proprietary chromatography.

Sterilität: Sterile filtered

Immunogen: A synthetic peptide corresponding to human RBP2, aa 1416-1434.

Klon: 9A6

Isotyp: IgG2a kappa

Anwendungsinformationen

Applikationshinweise: 1. Western blotting: ~1 g/mL
Other applications were not tested.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 mg/mL

Buffer: PBS, 50 % glycerol

Konservierungsmittel: Azide free

Lagerung: -20 °C

Informationen zur Lagerung: Upon arrival centrifuge briefly, aliquot and store at -20 C

Details zu KDM5A

Target: KDM5A (Lysine (K)-Specific Demethylase 5A (KDM5A))

Andere Bezeichnung: KDM5A (KDM5A Produkte)

Synonyme: Jarid1a antikoerper, JARID1A antikoerper, RBBP-2 antikoerper, RBBP2 antikoerper, RBP2 antikoerper, AA409370 antikoerper, C76986 antikoerper, Rbbp2 antikoerper, lysine demethylase 5A antikoerper, lysine (K)-specific demethylase 5A antikoerper, Kdm5a antikoerper, KDM5A antikoerper

Hintergrund: RBP2 (1,690 aa, 192 kDa) was originally identified as a retinoblastoma binding protein. It is also known as JARID1A (Jumonji, AT rich interactive domain 1A) and KDM5A (gene name). RBP2 plays both negative and positive roles in RB-mediated transcriptional activation, depending on the kinds of genes and regulates differentiation by its function as an H3K4 histone demethylase.

UniProt: P29375, Q3UXZ9

Pathways: Chromatin Binding, Warburg Effekt